One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern

One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern

A carbapenem-resistant Enterobacterales outbreak at a veterinary teaching hospital in the United States increased urgency for improved communication among diagnostic laboratories, public health authorities, veterinarians, and pet owners. Kansas State University, University of Missouri, Kansas Depar...

Descripció completa

Dades bibliogràfiques
Autors principals:	Kate KuKanich, Amy Burklund, Rob McGaughey, Nancy Muturi, Sasha Thomason, M.M. Chengappa, Ingrid Garrison, Bryna Stacey, Shuping Zhang, Tamara Gull
Format:	Article
Idioma:	English
Publicat:	Centers for Disease Control and Prevention 2023-06-01
Col·lecció:	Emerging Infectious Diseases
Matèries:	carbapenem-resistant Enterobacterales One Health carbapenem-resistant companion animals educational flyers Enterobacterales
Accés en línia:	https://wwwnc.cdc.gov/eid/article/29/6/22-1648_article

Ítems similars

Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update
per: M Lowe, et al.
Publicat: (2022-08-01)

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales
per: Tuğba Pamukçu, et al.
Publicat: (2024-12-01)

Carbapenemase producing Enterobacterales at a large teaching hospital in Ohio: comparison to state surveillance and retrospective analysis of patient characteristics
per: Amanda Carroll, et al.
Publicat: (2024-06-01)

High prevalence of carbapenem-resistant Enterobacterales (CRE) in human samples from Nigeria: A systematic review and meta-analysis
per: Ahmad Adebayo Irekeola, et al.
Publicat: (2024-08-01)

Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia
per: Alice Ying-Jung Wu, et al.
Publicat: (2022-12-01)

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas
per: Cody A. Black, et al.
Publicat: (2021-02-01)

In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan
per: Chun-Fu Huang, et al.
Publicat: (2023-04-01)

Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales
per: Isaac Alonso-García, et al.
Publicat: (2023-06-01)

Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients
per: Yu-Cheng Liu, et al.
Publicat: (2023-02-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
per: Shrief R, et al.
Publicat: (2022-10-01)

Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
per: Keisuke Oka, et al.
Publicat: (2022-06-01)

Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies
per: Jialiang Xu, et al.
Publicat: (2024-11-01)

Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021
per: Jens Thomsen, et al.
Publicat: (2023-12-01)

Carbapenem-Resistant and Extended-Spectrum β-Lactamase–Producing Enterobacterales in Children, United States, 2016–2020
per: Heather N. Grome, et al.
Publicat: (2024-06-01)

Carbapenem- and colistin-resistant Enterobacterales in intensive care unit patients in Mediterranean countries, 2019
per: Sandra Dos Santos, et al.
Publicat: (2024-04-01)

Expansion of KPC-producing Enterobacterales in four large hospitals in Hanoi, Vietnam
per: Tran Dieu Linh, et al.
Publicat: (2021-12-01)

The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital
per: Watcharaphon Tangsawad, et al.
Publicat: (2022-09-01)

Fecal Carriage of Carbapenem Resistant Enterobacterales and Associated Factors Among Admitted Patients in Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
per: Mekonnen Y, et al.
Publicat: (2023-09-01)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
per: Keith S. Kaye, et al.
Publicat: (2023-02-01)

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
per: Ilhaam Abrahams, et al.
Publicat: (2023-01-01)

Epidemiological and clinical characteristics of patients with carbapenem-resistant Enterobacterales in a university hospital of Colombia: Enzyme coproductions in rise
per: Juan Fernando Contreras-Valero, et al.
Publicat: (2024-07-01)

Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis
per: Yan Chen, et al.
Publicat: (2022-04-01)

Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections
per: Luca Mezzadri, et al.
Publicat: (2024-12-01)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
per: Fang Kang Lim, et al.
Publicat: (2020-10-01)

Molecular epidemiology and mechanisms of carbapenem and colistin resistance in Klebsiella and other Enterobacterales from treated wastewater in Croatia
per: Ana Puljko, et al.
Publicat: (2024-03-01)

Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing Enterobacterales: A Retrospective Study
per: Assaf Adar, et al.
Publicat: (2021-02-01)

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study
per: Gaurav Verma, et al.
Publicat: (2023-12-01)

Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China
per: Yinping Wang, et al.
Publicat: (2024-12-01)

A Review of Carbapenem Resistance in <i>Enterobacterales</i> and Its Detection Techniques
per: Oznur Caliskan-Aydogan, et al.
Publicat: (2023-06-01)

Risk factors and molecular epidemiology of colonizing carbapenem-resistant Enterobacterales in pediatric inpatient in Shenzhen, China
per: Hongmei Yang, et al.
Publicat: (2025-01-01)

Clinical Outcomes Associated with Co-infection of Carbapenem-Resistant Enterobacterales and other Multidrug-Resistant Organisms
per: Bekana K. Tadese, et al.
Publicat: (2022-12-01)

Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review
per: Moloto Kedišaletše, et al.
Publicat: (2023-12-01)

Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019
per: Anja von Laer, et al.
Publicat: (2022-02-01)

Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital
per: Erica De Vita, et al.
Publicat: (2023-09-01)

Evaluating the Performance of Two Rapid Immunochromatographic Techniques for Detecting Carbapenemase in Carbapenem-Resistant Enterobacterales Clinical Isolates
per: Liu P, et al.
Publicat: (2025-03-01)

In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales
per: Lu G, et al.
Publicat: (2022-12-01)

Characterization of Enterobacterales growing on selective CPE screening plates with a focus on non-carbapenemase-producing strains
per: Reut Efrati Epchtien, et al.
Publicat: (2025-02-01)

The Ever-Worsening Antimicrobial Resistance in Enterobacterales; A wakeup call
per: Fatima Ali, et al.
Publicat: (2023-04-01)

Antimicrobial stewardship programme associated with earlier prescription of in vitro susceptible therapy and lower 14-day mortality in patients with carbapenem-resistant Enterobacterales bacteraemia: a cohort study
per: Andressa Barros, et al.
Publicat: (2022-03-01)

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study
per: Almangour TA, et al.
Publicat: (2022-01-01)